Abstract
Evidence of the existence of two forms of cyclooxygenases and the clinical relevance of COX-2 inhibition led to the development of COX-2 selective NSAIDs. In order to evaluate this selectivity, we have developed and validated an enzymatic method. The precision and reproducibility of the assay were determined and COX-2 selectivity examined using nimesulide and indometacin.
Original language | English |
---|---|
Pages (from-to) | 89-90 |
Number of pages | 2 |
Journal | Journal de Pharmacie de Belgique |
Volume | 54 |
Issue number | 3 |
Publication status | Published - 1999 |
Keywords
- Cyclooxygenase 1
- Cyclooxygenase 2
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors
- Indomethacin
- Isoenzymes
- Prostaglandin-Endoperoxide Synthases
- Substrate Specificity
- Sulfonamides